364 related articles for article (PubMed ID: 31407469)
21. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
[TBL] [Abstract][Full Text] [Related]
22. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
[TBL] [Abstract][Full Text] [Related]
23. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
Guo Z; Wu Y; Chen J; Zhang S; Zhang C
Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
[TBL] [Abstract][Full Text] [Related]
24. Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.
Frazzoni M; Frazzoni L; Ribolsi M; Bortoli N; Tolone S; Russo S; Conigliaro R; Penagini R; Fuccio L; Zagari RM; Savarino E
Aliment Pharmacol Ther; 2022 Jun; 55(11):1423-1430. PubMed ID: 35229321
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
[TBL] [Abstract][Full Text] [Related]
26. Latin American consensus on diagnosis of gastroesophageal reflux disease.
Olmos JA; Pandolfino JE; Piskorz MM; Zamora N; Valdovinos Díaz MA; Remes Troche JM; Guzmán M; Hani A; Valdovinos García LR; Pitanga Lukashok H; Domingues G; Vesco E; Rivas MM; Ovalle LFP; Cisternas D; Vela MF
Neurogastroenterol Motil; 2024 Mar; 36(3):e14735. PubMed ID: 38225792
[TBL] [Abstract][Full Text] [Related]
27. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
Vardar R; Keskin M
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
[TBL] [Abstract][Full Text] [Related]
28. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
[TBL] [Abstract][Full Text] [Related]
29. The role of combined 24-h multichannel intraluminal impedance-pH monitoring in the evaluation of children with gastrointestinal symptoms suggesting gastro-esophageal reflux disease.
Hojsak I; Ivković L; Trbojević T; Pavić I; Jadrešin O; Mišak Z; Kolaček S
Neurogastroenterol Motil; 2016 Oct; 28(10):1488-93. PubMed ID: 27137138
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
31. Added Value of pH Multichannel Intraluminal Impedance in Adults Operated for Esophageal Atresia.
Gatzinsky V; Andersson O; Eriksson A; Jönsson L; Abrahamsson K; Sillén U
Eur J Pediatr Surg; 2016 Apr; 26(2):172-9. PubMed ID: 25643247
[TBL] [Abstract][Full Text] [Related]
32. Obesity does not affect treatment outcomes with proton pump inhibitors.
Sharma P; Vakil N; Monyak JT; Silberg DG
J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
[TBL] [Abstract][Full Text] [Related]
33. Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics.
Ribolsi M; Savarino E; Rogers B; Rengarajan A; Coletta MD; Ghisa M; Cicala M; Gyawali CP
J Neurogastroenterol Motil; 2021 Oct; 27(4):565-573. PubMed ID: 34045366
[TBL] [Abstract][Full Text] [Related]
34. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease.
Pilic D; Hankel S; Koerner-Rettberg C; Hamelmann E; Schmidt-Choudhury A
Scand J Gastroenterol; 2013 Jul; 48(7):785-93. PubMed ID: 23795658
[TBL] [Abstract][Full Text] [Related]
35. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
[TBL] [Abstract][Full Text] [Related]
36. The Lyon Consensus: Does It Differ From the Previous Ones?
Ghisa M; Barberio B; Savarino V; Marabotto E; Ribolsi M; Bodini G; Zingone F; Frazzoni M; Savarino E
J Neurogastroenterol Motil; 2020 Jul; 26(3):311-321. PubMed ID: 32606254
[TBL] [Abstract][Full Text] [Related]
37. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
[TBL] [Abstract][Full Text] [Related]
38. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
Shetler KP; Bikhtii S; Triadafilopoulos G
Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475749
[TBL] [Abstract][Full Text] [Related]
39. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring.
Conchillo JM; Schwartz MP; Selimah M; Samsom M; Sifrim D; Smout AJ
Dig Dis Sci; 2008 Jun; 53(6):1506-12. PubMed ID: 17934853
[TBL] [Abstract][Full Text] [Related]
40. Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia.
Ribolsi M; Biasutto D; Giordano A; Balestrieri P; Cicala M
J Clin Gastroenterol; 2018 Aug; 52(7):607-613. PubMed ID: 28787356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
